This randomized clinical trial includes preterm infants with a gestational age of 25 to 28 weeks who were supported with continuous positive airway pressure and compares the effect of selective application of minimally invasive surfactant therapy at a low fraction of inspired oxygen threshold vs control treatment on survival without bronchopulmonary dysplasia.
Source: JAMA Online First